Ryan J. Watts - 06 Jan 2025 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)

Signature
/s/ Tyler Nielsen, by power of attorney
Issuer symbol
DNLI
Transactions as of
06 Jan 2025
Transactions value $
-$750,955
Form type
4
Filing time
08 Jan 2025, 20:24:43 UTC
Previous filing
07 Jan 2025
Next filing
11 Jul 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNLI Common Stock Sale -$592K -29.3K -10.09% $20.22 261K 06 Jan 2025 Direct F1, F2, F3
transaction DNLI Common Stock Sale -$159K -7.65K -2.93% $20.81 253K 07 Jan 2025 Direct F1, F3
holding DNLI Common Stock 2.2M 06 Jan 2025 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.
F2 The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.91 to $20.23 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
F3 Includes 177,940 Unvested RSUs.
F4 The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.